Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …

Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous
community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 …

An integrative multi-modal metabolic phenotyping model was developed to assess the
systemic plasma sequelae of SARS-CoV-2 (rRT-PCR positive) induced COVID-19 disease …

A complex interplay exists between plasma lipoproteins and inflammation, as evidenced
from studies on atherosclerosis. Alterations in plasma lipoprotein levels in the context of …

Background Diagnostic approaches like the nuclear magnetic resonance spectroscopy
(NMR) based quantification of metabolites, lipoproteins, and inflammation markers has …

Quantitative nuclear magnetic resonance (NMR) spectroscopy of blood plasma is widely
used to investigate perturbed metabolic processes in human diseases. The reliability of …

Background Remnant cholesterol (RC) can partly explain the residual risk in atherosclerotic
cardiovascular disease (ASCVD). A consensus method of measuring RC levels has not …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Pulmonary arterial hypertension (PAH) is a cardiopulmonary disease with high mortality. In
recent years, it has been recognized that PAH is a multi-organ system disease, involving the …